产品详情
靶点信息
EGFR (Cell-free assay) | HER2 (Cell-free assay) | PDGFR (Cell-free assay) | ||
3 nM | >100 μM | >100 μM |
In vitro (25°C) | DMSO | 25 mg/mL (79.17 mM) | |
Water | Insoluble | ||
Ethanol | 13 mg/mL (41.17 mM) | ||
In vivo | 15% Captisol | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 31.67 mL | 158.33 mL | 316.66 mL |
0.5 mM | 6.33 mL | 31.67 mL | 63.33 mL |
1 mM | 3.17 mL | 15.83 mL | 31.67 mL |
5 mM | 0.63 mL | 3.17 mL | 6.33 mL |
*The above data is based on the productmolecular weight 315.8 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11022 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 315.8 |
Formula | C16H14ClN3O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 153436-53-4 |
Synonyms | AG1478, AG 1478 |
SMILES | COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Cl)OC |
产品资料
产品标签
Product Questions
Product Questions
Canertinib (CI-1033)
Canertinib (CI-1033)是一种不可逆的酪氨酸激酶抑制剂,对EGFR(IC50 0.8 nM),HER-2(IC50 19 nM)和ErbB-4(IC50 7 nM)…
PF299804 (Dacomitinib, PF299)
PF299804是一种有效的,可口服的酪氨酸激酶人表皮生长因子受体(HER)1(EGFR),HER2和HER4不可逆抑制剂。
AZD-9291 (Osimertinib)
AZD-9291 (Osimertinib)是第三代EGFR抑制剂,在临床前研究中显示出希望,并为已对现有EGFR抑制剂产生耐药性的…
CO-1686 (Rociletinib, AVL-301)
CO-1686是一种新型的口服靶向共价(不可逆)抑制剂,可抑制表皮生长因子受体(EGFR)的致癌突变形式,目…